Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
First Treatment for Neuromyelitis Optica Spectrum Disorder Approved
Rituxan Gets Priority Review for Pediatric Granulomatosis With Polyangiitis and Microscopic Polyangiitis
FDA Accepts BLA for Tissue Based Regenerative Tx for Pediatric Congenital Athymia
Jakafi Approved for Steroid-Refractory Acute Graft-Versus-Host Disease
Ruzurgi Approved for Pediatric Patients With Lambert-Eaton Myasthenic Syndrome
Novel Treatment for Neuromyelitis Optica Spectrum Disorder Gets Breakthrough Status From FDA
Elafibranor Gets Breakthrough Therapy Designation for Primary Biliary Cholangitis
Is There Evidence to Support Kombucha Health Claims in Humans?
Asceniv Approved for Primary Humoral Immunodeficiency in Adolescents, Adults
Investigational Treatment for Farber Disease Gets Fast Track, Rare Pediatric Disease Designations
Is Peppermint Oil an Effective Treatment for Irritable Bowel Syndrome?
Report Details Case of Hydrochlorothiazide-Induced Lupus
Envarsus XR Approved for New de novo Indication
Baricitinib Gets Fast Track Status for Systemic Lupus Erythematosus
Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury
Opioid Use High in Patients With Systemic Lupus Erythematosus
Jakafi Granted Priority Review for Acute Graft-Versus-Host Disease
Researchers Debate Hydroxychloroquine Dosing in SLE